
There is currently no warning information available for this product. We apologize for any inconvenience.
There is currently no manufacturer warning information available for this drug.
INDICATIONS
XylaMed™ should be used in horses and Cervidae (Fallow Deer, Mule Deer, Sika Deer, White-Tailed Deer, and Elk) when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia.
Horses: XylaMed™ has been used successfully as follows:
1.Diagnostic procedures-oral and ophthalmic examinations, abdominal palpation, rectal palpation, vaginal examination, catheterization of the bladder and radiographic examinations.
2.Orthopedic procedures, such as application of casting materials and splints.
3.Dental procedures.
4.Minor surgical procedures of short duration such as debridement, removal of cutaneous neoplasms and suturing of lacerations.
5.To calm and facilitate handling of fractious animals.
6.Therapeutic medication for sedation and relief of pain following injury or surgery.
7.Major surgical procedures:
a.When used as a preanesthetic to general anesthesia.
b.When used in conjunction with local anesthetics.
Cervidae: XylaMed™ may be used for the following:
1.To calm and facilitate handling of fractious animals.
2.Diagnostic procedures.
3.Minor surgical procedures.
4.Therapeutic medication for sedation and relief of pain following injury or surgery.
5.As a preanesthetic to local anesthesia.
XylaMed™ at the recommended dosages can be used in conjunction with local anesthetics, such as procaine or lidocaine.
XylaMed™
(xylazine) 100 mg/mL Injection
SEDATIVE AND ANALGESIC FOR USE IN HORSES AND CERVIDAE ONLY
NOT FOR HUMAN USE
KEEP OUT OF REACH OF CHILDREN
CAUTION
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Do not use in Cervidae less than 15 days before, or during the hunting season.
DESCRIPTION
XylaMed™ (xylazine) is supplied in 50 ml multiple-dose vials as a sterile solution. Each mL contains 100 mg XylaMed™ (xylazine base equivalent); 0.9 mg methylparaben; 0.1 mg propylparaben; water for injection; citric acid and sodium citrate for pH adjustment to 5.5 ± 0.3.
ACTIVE INGREDIENT:
xylazine hydrochloride …………………………………………………………………………….. 11.7%
(Equivalent to 10% base)
INERT INGREDIENTS: ……………………………………………………………………………….. 88.3%
100.0%